Researchers are uncovering how disrupted glutamatergic synapses drive diverse forms of intellectual disability, revealing new ...
Low-grade brain tumors known as IDH-mutant gliomas CNS WHO grade 2 are life-threatening in spite of their slow growth.
Cervical cancer detection and diagnosis are undergoing a transformation with the integration of advanced deep learning (DL) technologies. Despite ...
The FDA has granted 510(k) clearance to Brain Mets, an AI-based software platform designed to aid in the detection, tracking and treatment planning of brain metastases. The tool, developed by Neosoma, ...
Scientists have identified a promising target for treatment of a devastating autoimmune disease affecting the brain.